Being part of a study whose funding might be cut
What does it feel like to be part of a study which might have its funding cut? Marty Reiswig has a rare genetic mutation that means he will get Alzheimer’s disease in his forties or fifties. For ...
STAT3h
At meeting on guardrails for gene editing of human embryos, some call for a dead end
At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
The Johns Hopkins News-Letter5h
Professor Greg Lang highlights experimental evolution of yeast and nontransitive interactions
On Thursday, March 13, the Department of Biology hosted Greg Lang, associate professor of biological sciences at Lehigh ...
Zacks Investment Research on MSN23h
IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi
Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...